Audentes Therapeutics, Inc. BOLD
We take great care to ensure that the data presented and summarized in this overview for Audentes Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BOLD
Top Purchases
Top Sells
About BOLD
Insider Transactions at BOLD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,003
-0.25%
|
$630,105
$35.48 P/Share
|
|
Mar 09
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
80,000
-0.74%
|
$2,800,000
$35.66 P/Share
|
|
Mar 08
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
58,428
-1.58%
|
$1,986,552
$34.06 P/Share
|
|
Mar 06
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,372
-0.31%
|
$375,276
$33.03 P/Share
|
|
Mar 05
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
200
-0.01%
|
$7,200
$36.06 P/Share
|
|
Mar 02
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
421,638
-5.15%
|
$14,757,330
$35.7 P/Share
|
|
Sep 29
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
672,000
-14.0%
|
$18,816,000
$28.25 P/Share
|
|
Sep 07
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,000
-0.1%
|
$110,000
$22.35 P/Share
|
|
Sep 07
2017
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
5,000
+0.1%
|
$75,000
$15.03 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders